Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.
MeiraGTx is a gene therapy company, which is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.